These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination. Cheng C; Wang L; Gall JG; Nason M; Schwartz RM; McElrath MJ; DeRosa SC; Hural J; Corey L; Buchbinder SP; Nabel GJ PLoS One; 2012; 7(4):e33969. PubMed ID: 22496775 [TBL] [Abstract][Full Text] [Related]
7. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Hashimoto M; Boyer JL; Hackett NR; Wilson JM; Crystal RG Infect Immun; 2005 Oct; 73(10):6885-91. PubMed ID: 16177368 [TBL] [Abstract][Full Text] [Related]
8. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Seregin SS; Amalfitano A Expert Opin Biol Ther; 2009 Dec; 9(12):1521-31. PubMed ID: 19780714 [TBL] [Abstract][Full Text] [Related]